Purdue Pharma

Canada

Back to Profile

1-59 of 59 for Purdue Pharma Sort by
Query
Aggregations
IP Type
        Trademark 55
        Patent 4
Jurisdiction
        Canada 53
        World 4
        Europe 2
Date
2021 1
Before 2021 58
IPC Class
A61K 31/485 - Morphinan derivatives, e.g. morphine, codeine 2
A61J 3/07 - Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use 1
A61K 31/428 - Thiazoles condensed with carbocyclic rings 1
A61K 31/4458 - Non-condensed piperidines, e.g. piperocaine only substituted in position 2, e.g. methylphenidate 1
A61K 47/02 - Inorganic compounds 1
See more
NICE Class
05 - Pharmaceutical, veterinary and sanitary products 54
44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services 11
10 - Medical apparatus and instruments 7
42 - Scientific, technological and industrial services, research and design 7
35 - Advertising and business services 6
See more

1.

ELVIUM

      
Application Number 214718800
Status Registered
Filing Date 2021-11-15
Registration Date 2023-10-04
Owner Purdue Pharma (Canada)
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 10 - Medical apparatus and instruments
  • 35 - Advertising and business services
  • 40 - Treatment of materials; recycling, air and water treatment,
  • 42 - Scientific, technological and industrial services, research and design
  • 44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services

Goods & Services

(1) Pharmaceutical preparations, namely, pharmaceutical preparations for the relief of pain; pharmaceutical preparation, namely, bronchodilator; pharmaceutical preparations for the treatment of disorders of the eye; pharmaceutical preparations, namely, biopharmaceutical preparations, namely, biopharmaceuticals for the treatment of cancer; pharmaceutical preparations for use in immunotherapies; anti-emetic preparations; anaesthetic, pre-anaesthetic and analgesic pharmaceutical preparations, namely, anaesthetics for surgical use, general anaesthetics, inhalant anaesthetics, local anaesthetics, topical anaesthetics; inhalable anaesthetic, pre-anaesthetic and analgesic pharmaceutical preparations; bronchodilating pharmaceutical preparations; pharmaceutical preparations for the treatment of insomnia and sleep disorders; opioid antagonist pharmaceutical preparations; pharmaceutical preparations for the treatment of opioid overdose; nasal spray preparations; pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, attention deficit disorder, attention deficit hyperactivity disorder, hyperactivity, cognitive impairment disorders, mood disorders, oppositional defiance disorder, conduct disorder, learning disabilities, autism spectrum disorder, tic disorders, binge eating and obsessive eating disorders, anxiety disorders, substance abuse disorders, depression, psychosis; pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, namely, attention deficit disorder, attention deficit hyperactivity disorder, hyperactivity, cognitive impairment disorders; pharmaceutical preparations for the treatment of nerve diseases and disorders, namely, Alzheimer's disease, Parkinson's disease, Huntington's disease, epilepsy, cerebral palsy and multiple sclerosis; pharmaceutical preparations for the treatment of psychiatric diseases and disorders, namely, mood disorders, anxiety disorders, cognitive disorders, schizophrenia and bipolar disorders; ophthalmic pharmaceutical preparations; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for use in oncology; pharmaceutical preparations for the treatment of chronic pain; pharmaceutical anti-allergic preparations and substances; pharmaceutical preparations for the treatment of anaphylactic reactions; drug delivery agents in the form of films that facilitate the delivery of pharmaceutical preparations; pharmaceutical preparations for the treatment of osteoarthritic pain (2) Inhalers for therapeutic use; inhalers for medical purposes sold empty; medical devices and apparatus for the delivery of anaesthetic, pre-anaesthetic and analgesic substances (1) Wholesale and online sales of pharmaceutical preparations, and medical devices and supplies (2) Custom manufacture of pharmaceutical preparations, and medical devices and supplies (3) Research and development in the fields of pharmaceutical preparations, and medical devices and supplies (4) Providing information to health care providers about pharmaceutical preparations; providing information about the treatment of human diseases and disorders, namely insomnia and sleep disorders, diseases and disorders of the central nervous system, nerve diseases and disorders, psychiatric diseases and disorders, cancer

2.

PELMEG

      
Application Number 201771000
Status Registered
Filing Date 2020-03-16
Registration Date 2023-09-06
Owner Purdue Pharma (Canada)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparation for hematopoietic growth factors; pharmaceutical preparation, namely recombinant human granulocyte colony stimulating factor, for use in stimulating white blood cell production

3.

ELVIUM SCIENCES DE LA VIE

      
Application Number 197790700
Status Registered
Filing Date 2019-07-29
Registration Date 2023-10-04
Owner PURDUE PHARMA (Canada)
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 10 - Medical apparatus and instruments
  • 35 - Advertising and business services
  • 40 - Treatment of materials; recycling, air and water treatment,
  • 42 - Scientific, technological and industrial services, research and design
  • 44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services

Goods & Services

(1) Pharmaceutical preparations, namely, pharmaceutical preparations for the relief of pain; pharmaceutical preparation, namely, bronchodilator; pharmaceutical preparations for the treatment of disorders of the eye; pharmaceutical preparations, namely, biopharmaceutical preparations, namely, biopharmaceuticals for the treatment of cancer; pharmaceutical preparations for use in immunotherapies; anti-emetic preparations; anaesthetic, pre-anaesthetic and analgesic pharmaceutical preparations, namely, anaesthetics for surgical use, general anaesthetics, inhalant anaesthetics, local anaesthetics, topical anaesthetics; inhalable anaesthetic, pre-anaesthetic and analgesic pharmaceutical preparations; bronchodilating pharmaceutical preparations; pharmaceutical preparations for the treatment of insomnia and sleep disorders; opioid antagonist pharmaceutical preparations; pharmaceutical preparations for the treatment of opioid overdose; nasal spray preparations; pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, attention deficit disorder, attention deficit hyperactivity disorder, hyperactivity, cognitive impairment disorders, mood disorders, oppositional defiance disorder, conduct disorder, learning disabilities, autism spectrum disorder, tic disorders, binge eating and obsessive eating disorders, anxiety disorders, substance abuse disorders, depression, psychosis; pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, namely, attention deficit disorder, attention deficit hyperactivity disorder, hyperactivity, cognitive impairment disorders; pharmaceutical preparations for the treatment of nerve diseases and disorders, namely, Alzheimer's disease, Parkinson's disease, Huntington's disease, epilepsy, cerebral palsy and multiple sclerosis; pharmaceutical preparations for the treatment of psychiatric diseases and disorders, namely, mood disorders, anxiety disorders, cognitive disorders, schizophrenia and bipolar disorders; ophthalmic pharmaceutical preparations; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for use in oncology; pharmaceutical preparations for the treatment of chronic pain; pharmaceutical anti-allergic preparations and substances; pharmaceutical preparations for the treatment of anaphylactic reactions; drug delivery agents in the form of films that facilitate the delivery of pharmaceutical preparations; pharmaceutical preparations for the treatment of osteoarthritic pain (2) Inhalers for therapeutic use; inhalers for medical purposes sold empty; medical devices and apparatus for the delivery of anaesthetic, pre-anaesthetic and analgesic substances (1) Wholesale and online sales of pharmaceutical preparations, and medical devices and supplies (2) Custom manufacture of pharmaceutical preparations, and medical devices and supplies (3) Research and development in the fields of pharmaceutical preparations, and medical devices and supplies (4) Providing information to health care providers about pharmaceutical preparations; providing information about the treatment of human diseases and disorders, namely insomnia and sleep disorders, diseases and disorders of the central nervous system, nerve diseases and disorders, psychiatric diseases and disorders, cancer

4.

ELVIUM SCIENCES DE LA VIE

      
Application Number 197790600
Status Registered
Filing Date 2019-07-29
Registration Date 2023-10-04
Owner PURDUE PHARMA (Canada)
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 10 - Medical apparatus and instruments
  • 35 - Advertising and business services
  • 40 - Treatment of materials; recycling, air and water treatment,
  • 42 - Scientific, technological and industrial services, research and design
  • 44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services

Goods & Services

(1) Pharmaceutical preparations, namely, pharmaceutical preparations for the relief of pain; pharmaceutical preparation, namely, bronchodilator; pharmaceutical preparations for the treatment of disorders of the eye; pharmaceutical preparations, namely, biopharmaceutical preparations, namely, biopharmaceuticals for the treatment of cancer; pharmaceutical preparations for use in immunotherapies; anti-emetic preparations; anaesthetic, pre-anaesthetic and analgesic pharmaceutical preparations, namely, anaesthetics for surgical use, general anaesthetics, inhalant anaesthetics, local anaesthetics, topical anaesthetics; inhalable anaesthetic, pre-anaesthetic and analgesic pharmaceutical preparations; bronchodilating pharmaceutical preparations; pharmaceutical preparations for the treatment of insomnia and sleep disorders; opioid antagonist pharmaceutical preparations; pharmaceutical preparations for the treatment of opioid overdose; nasal spray preparations; pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, attention deficit disorder, attention deficit hyperactivity disorder, hyperactivity, cognitive impairment disorders, mood disorders, oppositional defiance disorder, conduct disorder, learning disabilities, autism spectrum disorder, tic disorders, binge eating and obsessive eating disorders, anxiety disorders, substance abuse disorders, depression, psychosis; pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, namely, attention deficit disorder, attention deficit hyperactivity disorder, hyperactivity, cognitive impairment disorders; pharmaceutical preparations for the treatment of nerve diseases and disorders, namely, Alzheimer's disease, Parkinson's disease, Huntington's disease, epilepsy, cerebral palsy and multiple sclerosis; pharmaceutical preparations for the treatment of psychiatric diseases and disorders, namely, mood disorders, anxiety disorders, cognitive disorders, schizophrenia and bipolar disorders; ophthalmic pharmaceutical preparations; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for use in oncology; pharmaceutical preparations for the treatment of chronic pain; pharmaceutical anti-allergic preparations and substances; pharmaceutical preparations for the treatment of anaphylactic reactions; drug delivery agents in the form of films that facilitate the delivery of pharmaceutical preparations; pharmaceutical preparations for the treatment of osteoarthritic pain (2) Inhalers for therapeutic use; inhalers for medical purposes sold empty; medical devices and apparatus for the delivery of anaesthetic, pre-anaesthetic and analgesic substances (1) Wholesale and online sales of pharmaceutical preparations, and medical devices and supplies (2) Custom manufacture of pharmaceutical preparations, and medical devices and supplies (3) Research and development in the fields of pharmaceutical preparations, and medical devices and supplies (4) Providing information to health care providers about pharmaceutical preparations; providing information about the treatment of human diseases and disorders, namely insomnia and sleep disorders, diseases and disorders of the central nervous system, nerve diseases and disorders, psychiatric diseases and disorders, cancer

5.

ELVIUM LIFE SCIENCES

      
Application Number 194407700
Status Registered
Filing Date 2019-02-01
Registration Date 2023-08-25
Owner Purdue Pharma (Canada)
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 10 - Medical apparatus and instruments
  • 35 - Advertising and business services
  • 40 - Treatment of materials; recycling, air and water treatment,
  • 42 - Scientific, technological and industrial services, research and design
  • 44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services

Goods & Services

(1) Pharmaceutical preparations, namely, pharmaceutical preparations for the relief of pain; pharmaceutical preparation, namely, bronchodilator; pharmaceutical preparations for the treatment of disorders of the eye; pharmaceutical preparations, namely, biopharmaceutical preparations, namely, biopharmaceuticals for the treatment of cancer; pharmaceutical preparations for use in immunotherapies; anti-emetic preparations; anaesthetic, pre-anaesthetic and analgesic pharmaceutical preparations, namely, anaesthetics for surgical use, general anaesthetics, inhalant anaesthetics, local anaesthetics, topical anaesthetics; inhalable anaesthetic, pre-anaesthetic and analgesic pharmaceutical preparations; bronchodilating pharmaceutical preparations; pharmaceutical preparations for the treatment of insomnia and sleep disorders; opioid antagonist pharmaceutical preparations; pharmaceutical preparations for the treatment of opioid overdose; nasal spray preparations; pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, attention deficit disorder, attention deficit hyperactivity disorder, hyperactivity, cognitive impairment disorders, mood disorders, oppositional defiance disorder, conduct disorder, learning disabilities, autism spectrum disorder, tic disorders, binge eating and obsessive eating disorders, anxiety disorders, substance abuse disorders, depression, psychosis; pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, namely, attention deficit disorder, attention deficit hyperactivity disorder, hyperactivity, cognitive impairment disorders; pharmaceutical preparations for the treatment of nerve diseases and disorders, namely, Alzheimer's disease, Parkinson's disease, Huntington's disease, epilepsy, cerebral palsy and multiple sclerosis; pharmaceutical preparations for the treatment of psychiatric diseases and disorders, namely, mood disorders, anxiety disorders, cognitive disorders, schizophrenia and bipolar disorders; ophthalmic pharmaceutical preparations; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for use in oncology; pharmaceutical preparations for the treatment of chronic pain; pharmaceutical anti-allergic preparations and substances; pharmaceutical preparations for the treatment of anaphylactic reactions; drug delivery agents in the form of films that facilitate the delivery of pharmaceutical preparations; pharmaceutical preparations for the treatment of osteoarthritic pain (2) Inhalers for therapeutic use; inhalers for medical purposes sold empty; medical devices and apparatus for the delivery of anaesthetic, pre-anaesthetic and analgesic substances (1) Wholesale and online sales of pharmaceutical preparations, and medical devices and supplies (2) Custom manufacture of pharmaceutical preparations, and medical devices and supplies (3) Research and development in the fields of pharmaceutical preparations, and medical devices and supplies (4) Providing information to health care providers about pharmaceutical preparations; providing information about the treatment of human diseases and disorders, namely insomnia and sleep disorders, diseases and disorders of the central nervous system, nerve diseases and disorders, psychiatric diseases and disorders, cancer

6.

ELVIUM LIFE SCIENCES

      
Application Number 194409400
Status Registered
Filing Date 2019-02-01
Registration Date 2023-08-25
Owner Purdue Pharma (Canada)
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 10 - Medical apparatus and instruments
  • 35 - Advertising and business services
  • 40 - Treatment of materials; recycling, air and water treatment,
  • 42 - Scientific, technological and industrial services, research and design
  • 44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services

Goods & Services

(1) Pharmaceutical preparations, namely, pharmaceutical preparations for the relief of pain; pharmaceutical preparation, namely, bronchodilator; pharmaceutical preparations for the treatment of disorders of the eye; pharmaceutical preparations, namely, biopharmaceutical preparations, namely, biopharmaceuticals for the treatment of cancer; pharmaceutical preparations for use in immunotherapies; anti-emetic preparations; anaesthetic, pre-anaesthetic and analgesic pharmaceutical preparations, namely, anaesthetics for surgical use, general anaesthetics, inhalant anaesthetics, local anaesthetics, topical anaesthetics; inhalable anaesthetic, pre-anaesthetic and analgesic pharmaceutical preparations; bronchodilating pharmaceutical preparations; pharmaceutical preparations for the treatment of insomnia and sleep disorders; opioid antagonist pharmaceutical preparations; pharmaceutical preparations for the treatment of opioid overdose; nasal spray preparations; pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, attention deficit disorder, attention deficit hyperactivity disorder, hyperactivity, cognitive impairment disorders, mood disorders, oppositional defiance disorder, conduct disorder, learning disabilities, autism spectrum disorder, tic disorders, binge eating and obsessive eating disorders, anxiety disorders, substance abuse disorders, depression, psychosis; pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, namely, attention deficit disorder, attention deficit hyperactivity disorder, hyperactivity, cognitive impairment disorders; pharmaceutical preparations for the treatment of nerve diseases and disorders, namely, Alzheimer's disease, Parkinson's disease, Huntington's disease, epilepsy, cerebral palsy and multiple sclerosis; pharmaceutical preparations for the treatment of psychiatric diseases and disorders, namely, mood disorders, anxiety disorders, cognitive disorders, schizophrenia and bipolar disorders; ophthalmic pharmaceutical preparations; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for use in oncology; pharmaceutical preparations for the treatment of chronic pain; pharmaceutical anti-allergic preparations and substances; pharmaceutical preparations for the treatment of anaphylactic reactions; drug delivery agents in the form of films that facilitate the delivery of pharmaceutical preparations; pharmaceutical preparations for the treatment of osteoarthritic pain (2) Inhalers for therapeutic use; inhalers for medical purposes sold empty; medical devices and apparatus for the delivery of anaesthetic, pre-anaesthetic and analgesic substances (1) Wholesale and online sales of pharmaceutical preparations, and medical devices and supplies (2) Custom manufacture of pharmaceutical preparations, and medical devices and supplies (3) Research and development in the fields of pharmaceutical preparations, and medical devices and supplies (4) Providing information to health care providers about pharmaceutical preparations; providing information about the treatment of human diseases and disorders, namely insomnia and sleep disorders, diseases and disorders of the central nervous system, nerve diseases and disorders, psychiatric diseases and disorders, cancer

7.

AVRIO HEALTH

      
Application Number 193149700
Status Registered
Filing Date 2018-11-20
Registration Date 2021-07-02
Owner Purdue Pharma (Canada)
NICE Classes  ?
  • 01 - Chemical and biological materials for industrial, scientific and agricultural use
  • 03 - Cosmetics and toiletries; cleaning, bleaching, polishing and abrasive preparations
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 10 - Medical apparatus and instruments
  • 42 - Scientific, technological and industrial services, research and design

Goods & Services

(1) Natural and non-prescription health care products, namely, fatty acids for use as additives to foods and beverages for medical purposes (2) Cleansers, namely, skin cleansers; cleansers, namely, non-medicated wound cleansers; non-medicated skin creams, lotions, ointments and salves, non-medicated diaper rash cream, non-medicated anti-itch and dry-skin creams, cosmetic creams, lotions, ointments and salves for the face, hands and body, sunscreen preparations (3) Non-prescription pharmaceutical preparations for the treatment of minor wounds, cuts, boils, abrasions, skin tears and sores, burns, grazes, itching and irritation, rashes; non-prescription pharmaceutical preparations for veterinary medicine for the treatment of minor wounds, cuts, boils, abrasions, skin tears and sores, burns, grazes, itching and irritation, rashes; herbal supplements for general health and well-being; natural and non-prescription health care products, namely, amino acid dietary and nutritional supplements, fatty acid dietary and nutritional supplements, vitamin and mineral supplements, probiotic dietary and nutritional supplements; natural and non-prescription health care products, namely, amino acids, vitamins, minerals and probiotics for use as additives to foods and beverages for medical purposes; natural and nonprescription health care products, namely, dietetic substances adapted for medical purposes, containing amino acids, fatty acids, vitamins, minerals and probiotics; non-prescription laxatives; non-prescription pharmaceutical preparations, herbal supplements and natural and non-prescription health care products, namely, preparations, for alleviating constipation, aiding digestion, treating digestive disorders, treating nausea and vomiting, treating motion sickness and seasickness; non-prescription decongestants; nonprescription expectorants; non-prescription antihistamines; non-prescription pharmaceutical preparations, herbal supplements and natural and non-prescription health care products, namely, preparations for treating colds, coughs, nasal and sinus congestion, allergies; wound care products, namely, wound dressings, first aid dressings, pharmaceutical preparations for wounds, medicated cleansers for skin and wounds, adhesive wound closures, topical first aid gels; wound care products, namely, sanitizing wipes, and dressings, cloths and materials impregnated with non-prescription pharmaceutical preparations for use in dressing wounds; non-prescription antiseptics; non-prescription anti-viral preparations; medicated and non-medicated antiseptic solutions; topical anti-viral, anti-bacterial and anti-fungal antiseptics; cleansers, namely topical anti-viral, anti-bacterial and anti-fungal cleansers for skin and wounds, mouth cavity cleansers; medicated and non-medicated wipes and bandages for treating wounds; medicated creams, lotions, ointments and salves, namely, antifungal creams, lotions, ointments and salves for medical use, antibiotic creams, lotions, ointments and salves, multi-purpose medicated antibiotic creams, lotions, ointments and salves, medicated creams, lotions, ointments and salves for skin rashes, inflammation and common skin irritations, medicated anti-itch and dry skin creams, lotions, ointments and salves, hydrocortisone creams, lotions, ointments and salves, calamine lotion, hemorrhoidal creams and ointments; germicides; medicated throat sprays and rinses; medicated premoistened feminine towelettes and wipes; medicated feminine hygiene washes (4) Wound care products, namely, thermal packs for first aid purposes, cooling pads for first aid purposes (1) Research and development in the field of non-prescription pharmaceutical preparations, herbal supplements, and natural and non-prescription health care products

8.

AVRIO HEALTH

      
Application Number 187335700
Status Registered
Filing Date 2017-12-15
Registration Date 2021-07-02
Owner Purdue Pharma (Canada)
NICE Classes  ?
  • 01 - Chemical and biological materials for industrial, scientific and agricultural use
  • 03 - Cosmetics and toiletries; cleaning, bleaching, polishing and abrasive preparations
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 10 - Medical apparatus and instruments
  • 42 - Scientific, technological and industrial services, research and design

Goods & Services

(1) Natural and non-prescription health care products, namely, fatty acids for use as additives to foods and beverages for medical purposes (2) Cleansers, namely, skin cleansers; cleansers, namely, non-medicated wound cleansers; non-medicated skin creams, lotions, ointments and salves, non-medicated diaper rash cream, non-medicated anti-itch and dry-skin creams, cosmetic creams, lotions, ointments and salves for the face, hands and body, sunscreen preparations (3) Non-prescription pharmaceutical preparations for the treatment of minor wounds, cuts, boils, abrasions, skin tears and sores, burns, grazes, itching and irritation, rashes; non-prescription pharmaceutical preparations for veterinary medicine for the treatment of minor wounds, cuts, boils, abrasions, skin tears and sores, burns, grazes, itching and irritation, rashes; herbal supplements for general health and well-being; natural and non-prescription health care products, namely, amino acid dietary and nutritional supplements, fatty acid dietary and nutritional supplements, vitamin and mineral supplements, probiotic dietary and nutritional supplements; natural and non-prescription health care products, namely, amino acids, vitamins, minerals and probiotics for use as additives to foods and beverages for medical purposes; natural and nonprescription health care products, namely, dietetic substances adapted for medical purposes, containing amino acids, fatty acids, vitamins, minerals and probiotics; non-prescription laxatives; non-prescription pharmaceutical preparations, herbal supplements and natural and non-prescription health care products, namely, preparations, for alleviating constipation, aiding digestion, treating digestive disorders, treating nausea and vomiting, treating motion sickness and seasickness; non-prescription decongestants; nonprescription expectorants; non-prescription antihistamines; non-prescription pharmaceutical preparations, herbal supplements and natural and non-prescription health care products, namely, preparations for treating colds, coughs, nasal and sinus congestion, allergies; wound care products, namely, wound dressings, first aid dressings, pharmaceutical preparations for wounds, medicated cleansers for skin and wounds, adhesive wound closures, topical first aid gels; wound care products, namely, sanitizing wipes, and dressings, cloths and materials impregnated with non-prescription pharmaceutical preparations for use in dressing wounds; non-prescription antiseptics; non-prescription anti-viral preparations; medicated and non-medicated antiseptic solutions; topical anti-viral, anti-bacterial and anti-fungal antiseptics; cleansers, namely topical anti-viral, anti-bacterial and anti-fungal cleansers for skin and wounds, mouth cavity cleansers; medicated and non-medicated wipes and bandages for treating wounds; medicated creams, lotions, ointments and salves, namely, antifungal creams, lotions, ointments and salves for medical use, antibiotic creams, lotions, ointments and salves, multi-purpose medicated antibiotic creams, lotions, ointments and salves, medicated creams, lotions, ointments and salves for skin rashes, inflammation and common skin irritations, medicated anti-itch and dry skin creams, lotions, ointments and salves, hydrocortisone creams, lotions, ointments and salves, calamine lotion, hemorrhoidal creams and ointments; germicides; medicated throat sprays and rinses; medicated premoistened feminine towelettes and wipes; medicated feminine hygiene washes (4) Wound care products, namely, thermal packs for first aid purposes, cooling pads for first aid purposes (1) Research and development in the field of non-prescription pharmaceutical preparations, herbal supplements, and natural and non-prescription health care products

9.

NYXOID

      
Application Number 187061200
Status Registered
Filing Date 2017-11-30
Registration Date 2019-12-02
Owner Purdue Pharma (Canada)
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services

Goods & Services

(1) Opioid antagonist pharmaceutical preparations; pharmaceutical preparations for the treatment of opioid overdose; nasal spray preparations (1) Providing information in the field of opioid use and overdose; providing information to health care providers about pharmaceutical preparations for the treatment of opioid overdose; providing information to health care providers about pharmaceutical preparations for the treatment of opioid overdose via a website, the Internet or other global communication networks

10.

ADHANSIA

      
Application Number 017367211
Status Registered
Filing Date 2017-10-19
Registration Date 2018-03-21
Owner Purdue Pharma (Canada)
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services

Goods & Services

Pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system; pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, namely, attention deficit disorder, attention deficit hyperactivity disorder, hyperactivity, cognitive impairment disorders, mood disorders, oppositional defiance disorder, conduct disorder, learning disabilities, autism spectrum disorder, tic disorders, binge eating and obsessive eating disorders, anxiety disorders, substance abuse disorders, depression, psychosis. Providing information to health care providers about pharmaceutical preparations, including pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, via a website, the Internet or other global communication networks; providing information to health care providers about pharmaceutical preparations, including pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system.

11.

ADHANSIA

      
Application Number 183437600
Status Registered
Filing Date 2017-04-25
Registration Date 2020-01-15
Owner PURDUE PHARMA (Canada)
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services

Goods & Services

(1) Pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, namely, attention deficit disorder, attention deficit hyperactivity disorder, hyperactivity, cognitive impairment disorders, mood disorders, oppositional defiance disorder, conduct disorder, learning disabilities, autism spectrum disorder, tic disorders, binge eating and obsessive eating disorders, anxiety disorders, substance abuse disorders, depression, psychosis (1) Providing information to health care providers about pharmaceutical preparations, including pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, via a website, the Internet or other global communication networks; providing information to health care providers about pharmaceutical preparations, including pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system

12.

NORSPAN

      
Application Number 181498000
Status Registered
Filing Date 2016-12-19
Registration Date 2019-12-03
Owner Purdue Pharma (Canada)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparation, namely an analgesic administered transdermally via patches that adhere to the skin

13.

DUARMONY

      
Application Number 180404200
Status Registered
Filing Date 2016-10-11
Registration Date 2019-10-09
Owner Purdue Pharma (Canada)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) pharmaceutical substances and preparations for the treatment of pain

14.

DUARTZ

      
Application Number 180404300
Status Registered
Filing Date 2016-10-11
Registration Date 2019-10-09
Owner Purdue Pharma (Canada)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) pharmaceutical substances and preparations for the treatment of pain

15.

KOCLAREON

      
Application Number 180404400
Status Registered
Filing Date 2016-10-11
Registration Date 2019-10-09
Owner Purdue Pharma (Canada)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) pharmaceutical substances and preparations for the treatment of pain

16.

OXYCONTIN NEO

      
Application Number 179146100
Status Registered
Filing Date 2016-07-14
Registration Date 2019-07-11
Owner Purdue Pharma (Canada)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Preparation for the relief of pain.

17.

METHODS AND COMPOSITIONS PARTICULARLY FOR TREATMENT OF ATTENTION DEFICIT DISORDER

      
Application Number CA2015051109
Publication Number 2016/065481
Status In Force
Filing Date 2015-10-30
Publication Date 2016-05-06
Owner PURDUE PHARMA (Canada)
Inventor
  • Vargas Rincon, Ricardo Alberto
  • Reiz, Joseph Leonard

Abstract

There is described, inter alia, a coated bead comprising: (a) a granule; (b) a first layer coated over the granule, the first layer comprising a first amount of an active pharmaceutical ingredient comprising a central nervous system stimulant; and (c) a second layer coated over the first layer, the second layer being present in an amount sufficient to substantially delay release of the active pharmaceutical ingredient in the first layer until after the coated bead reaches a distal intestine portion of a subject to whom the coated bead is administered; and (d) the third layer coated over the second layer, the third layer comprising a second amount of the active pharmaceutical ingredient, the third layer being configured to permit substantially immediate release of the active pharmaceutical ingredient comprised therein. Embodiments related to a solid oral pharmaceutical composition are also described.

IPC Classes  ?

  • A61K 9/56 - Organic coatings
  • A61K 31/4458 - Non-condensed piperidines, e.g. piperocaine only substituted in position 2, e.g. methylphenidate
  • A61K 9/16 - AgglomeratesGranulatesMicrobeadlets
  • A61P 25/00 - Drugs for disorders of the nervous system
  • C07D 211/34 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

18.

REDUCING DRUG LIKING IN A SUBJECT

      
Application Number CA2015000206
Publication Number 2015/143548
Status In Force
Filing Date 2015-03-27
Publication Date 2015-10-01
Owner PURDUE PHARMA (Canada)
Inventor
  • Reiz, Joseph L.
  • Michalko, Kenneth J.

Abstract

There is described a method of reducing drug liking a subject comprising the step of administering to the subject an oral pharmaceutical composition comprising: (i) hydromorphone or a pharmaceutically acceptable salt thereof, and (ii) naloxone or a pharmaceutically acceptable salt thereof, wherein the oral pharmaceutical composition comprising (i) and (ii) in a weight ratio equal to or less than about 4:1. There is also described use of an oral pharmaceutical composition comprising: (i) hydromorphone or a pharmaceutically acceptable salt thereof, and (ii) naloxone or a pharmaceutically acceptable salt thereof, wherein the oral pharmaceutical composition comprising (i) and (ii) in a weight ratio equal to or less than about 4:1, for reducing drug liking in a subject. The present inventors have conducted clinical studies from which it can be concluded that that drug liking in opioid abusers can be reduced when the weight ratio of (i) and (ii) in an intravenous composition is equal to or less than about 4:1. Based on the these clinical studies, the present inventors have established a reasonable inference that similar results would be obtained in the case of oral pharmaceutical compositions having a corresponding weight ratio of (i) and (ii) - i.e., if such an oral composition were to be abused by extraction of (i) and (ii) therefrom, the resulting extraction composition would behave in a similar manner as the intravenous compositions used in the clinical studies reported herein.

IPC Classes  ?

  • A61K 31/485 - Morphinan derivatives, e.g. morphine, codeine
  • A61K 9/24 - Layered or laminated unitary dosage forms
  • A61P 25/04 - Centrally acting analgesics, e.g. opioids
  • A61P 25/36 - Opioid-abuse
  • C07D 489/02 - Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
  • C07D 489/08 - Oxygen atom

19.

FOQUEST

      
Application Number 014567804
Status Registered
Filing Date 2015-09-17
Registration Date 2016-01-22
Owner Purdue Pharma (Canada)
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 41 - Education, entertainment, sporting and cultural services

Goods & Services

Pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system; pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, namely, attention deficit disorder, attention deficit hyperactivity disorder, hyperactivity, cognitive impairment disorders, mood disorders, oppositional defiance disorder, conduct disorder, learning disabilities, autism spectrum disorder, tic disorders, binge eating and obsessive eating disorders, anxiety disorders, substance abuse disorders, depression, psychosis. Providing information to health care providers about pharmaceutical preparations, including pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, via a website, the Internet or other global communication networks; providing information to health care providers about pharmaceutical preparations, including pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system.

20.

FOQUEST

      
Application Number 172004800
Status Registered
Filing Date 2015-03-19
Registration Date 2017-12-28
Owner PURDUE PHARMA (Canada)
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services

Goods & Services

(1) Pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system; pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, namely, attention deficit disorder, attention deficit hyperactivity disorder, hyperactivity, cognitive impairment disorders. (1) Providing information to health care providers about pharmaceutical preparations, including pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, via a website, the Internet or other global communication networks; providing information to health care providers about pharmaceutical preparations, including pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system

21.

HYSINGLA

      
Application Number 170534300
Status Registered
Filing Date 2014-12-02
Registration Date 2019-11-21
Owner Purdue Pharma (Canada)
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services

Goods & Services

(1) Pharmaceutical preparations for the relief of pain. (1) Providing information to health care providers about pharmaceutical preparations, including pharmaceutical preparations for the relief of pain, via a website, the Internet or other global communication networks; providing information to health care providers about pharmaceutical preparations, including pharmaceutical preparations for the relief of pain.

22.

PHARMACEUTICAL COMPOSITIONS COMPRISING HYDROMORPHONE AND NALOXONE

      
Application Number CA2013000932
Publication Number 2014/071499
Status In Force
Filing Date 2013-11-06
Publication Date 2014-05-15
Owner PURDUE PHARMA (Canada)
Inventor Vargas Rincon, Ricardo Alberto

Abstract

Disclosed is a prolonged release pharmaceutical dosage form comprising a plurality of coated beads, each comprising a granule, a first layer coated on the granule comprising hydromorphone, naloxone, an antioxidant compound and a chelatmg compound; and a second layer coated on the first layer comprising a prolonged release agent. The dosage form has improved stability and dissolution properties. Also disclosed is the use of a combination of an antioxidant, such as sodium metabisulfite, and a chelatmg agent, such as EDTA, to improve the stability and/or dissolution properties of a prolonged release dosage form comprising hydromorphone and naloxone.

IPC Classes  ?

  • A61K 9/52 - Sustained or differential release type
  • A61K 31/485 - Morphinan derivatives, e.g. morphine, codeine
  • A61K 47/02 - Inorganic compounds
  • A61K 47/18 - AminesAmidesUreasQuaternary ammonium compoundsAmino acidsOligopeptides having up to five amino acids

23.

TECHNOLOGIE HTR

      
Application Number 167528800
Status Registered
Filing Date 2014-05-02
Registration Date 2019-09-17
Owner PURDUE PHARMA (Canada)
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services

Goods & Services

(1) Pain-relief tablets for oral consumption formed by a process that hardens the tablets, making them resistant to crushing; pharmaceutical preparations for the relief of pain in the form of tablets formed by a process that hardens the tablets, making them resistant to crushing. (1) Providing information to health care providers about pharmaceutical preparations, including pharmaceutical preparations for the relief of pain, via a website, the Internet or other global communication networks; providing information to health care providers about pharmaceutical preparations, including pharmaceutical preparations for the relief of pain.

24.

OxyNEO

      
Application Number 151739400
Status Registered
Filing Date 2011-03-02
Registration Date 2011-10-19
Owner Purdue Pharma (Canada)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Preparation for the relief of pain.

25.

ONCE-DAILY ORAL IR/CR PRAMIPEXOLE FORMULATION

      
Application Number CA2010000482
Publication Number 2010/115267
Status In Force
Filing Date 2010-04-07
Publication Date 2010-10-14
Owner PURDUE PHARMA (Canada)
Inventor Krishnamurthy, Thinnayam, Naganathan

Abstract

An oral once-daily pramipexole formulation, comprising an immediate-release component and a controlled-release component, is provided wherein in preferred embodiments, both the immediate-release component and the controlled-release component comprise pramipexole The formulation is preferably in the form of a coated bead A method of manufacturing said formulation is also provided.

IPC Classes  ?

  • A61K 31/428 - Thiazoles condensed with carbocyclic rings
  • A61J 3/07 - Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use
  • A61K 9/54 - Sustained or differential release type containing discrete particles with coatings of different thicknesses or different materials
  • A61P 25/14 - Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
  • A61P 25/16 - Anti-Parkinson drugs

26.

HTR TECHNOLOGY

      
Application Number 149884300
Status Registered
Filing Date 2010-10-07
Registration Date 2014-07-14
Owner Purdue Pharma (Canada)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Tablets for oral consumption formed by a process that hardens the tablets, making them resistant to crushing; pharmaceutical preparations for the relief of pain in the form of tablets formed by a process that hardens the tablets, making them resistant to crushing.

27.

SAFLUTAN Design

      
Application Number 148281500
Status Registered
Filing Date 2010-05-28
Registration Date 2016-11-23
Owner Purdue Pharma (Canada)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations, namely ophthalmic preparations for the treatment of glaucoma.

28.

TARGIN CONTROLLED RELEASE OXYCODONE/NALOXONE HCL TABLETS

      
Application Number 148214200
Status Registered
Filing Date 2010-05-21
Registration Date 2011-07-27
Owner Purdue Pharma (Canada)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Analgesic preparation for the relief of pain and preparation for the relief of opioid-induced constipation.

29.

SAFLUTAN

      
Application Number 145647800
Status Registered
Filing Date 2009-10-22
Registration Date 2016-10-27
Owner Purdue Pharma (Canada)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations, namely, ophthalmic preparations for the treatment of glaucoma.

30.

TARGIN

      
Application Number 131567300
Status Registered
Filing Date 2006-09-07
Registration Date 2010-10-06
Owner Purdue Pharma (Canada)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Analgesic preparation for the relief of pain.

31.

MLR

      
Application Number 126361900
Status Registered
Filing Date 2005-07-05
Registration Date 2010-01-22
Owner Purdue Pharma (Canada)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pellets or beads consisting of multiple layers of drug and drug release-controlling excipients, which are encapsulated for pharmaceutical purposes.

32.

HYDROMORPH.IR

      
Application Number 123626600
Status Registered
Filing Date 2004-11-04
Registration Date 2005-12-15
Owner Purdue Pharma (Canada)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Opioid pharmaceutical preparation for relief of pain, in capsule or tablet form.

33.

BUTRANS

      
Application Number 118068100
Status Registered
Filing Date 2003-06-09
Registration Date 2010-05-31
Owner Purdue Pharma (Canada)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparation, namely an analgesic administered transdermally via patches that adhere to the skin.

34.

PALLADONE IR

      
Application Number 111875300
Status Registered
Filing Date 2001-10-17
Registration Date 2003-01-15
Owner Purdue Pharma, (Canada)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparation for relief of pain, in capsule or tablet form.

35.

PALLADONE XL

      
Application Number 105774000
Status Registered
Filing Date 2000-05-03
Registration Date 2003-01-21
Owner Purdue Pharma, (Canada)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparation for the relief of pain, in capsule or tablet form.

36.

PURDUE

      
Application Number 104923200
Status Registered
Filing Date 2000-03-02
Registration Date 2003-09-10
Owner Purdue Pharma, (Canada)
NICE Classes  ? 35 - Advertising and business services

Goods & Services

(1) Research and development, production and distribution, sales of pharmaceuticals.

37.

BIPHENTIN

      
Application Number 089948800
Status Registered
Filing Date 1998-12-11
Registration Date 2006-09-19
Owner Purdue Pharma (Canada)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Central nervous system (CNS) stimulant.

38.

ZYTRAM XL

      
Application Number 085932400
Status Registered
Filing Date 1997-10-21
Registration Date 2007-04-13
Owner Purdue Pharma (Canada)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Analgesic preparation.

39.

OXY-IR

      
Application Number 084283000
Status Registered
Filing Date 1997-04-21
Registration Date 2001-02-26
Owner Purdue Pharma (Canada)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Preparation for relief of pain.

40.

CODEINE CONTIN

      
Application Number 079552700
Status Registered
Filing Date 1995-10-24
Registration Date 1997-06-16
Owner Purdue Pharma (Canada)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Analgesic preparations.

41.

CONTIN

      
Application Number 079552400
Status Registered
Filing Date 1995-10-24
Registration Date 1997-02-04
Owner Purdue Pharma (Canada)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceuticals, namely, a controlled-release system used as an ingredient in pharmaceutical preparations.

42.

OXYCONTIN

      
Application Number 079202400
Status Registered
Filing Date 1995-09-08
Registration Date 1997-04-23
Owner Purdue Pharma (Canada)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Preparation for relief of pain.

43.

MS CONTIN

      
Application Number 079202100
Status Registered
Filing Date 1995-09-08
Registration Date 1996-12-16
Owner Purdue Pharma (Canada)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Analgesic preparation.

44.

UNIPHYL

      
Application Number 079202300
Status Registered
Filing Date 1995-09-08
Registration Date 1997-02-12
Owner Purdue Pharma (Canada)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparation, namely, bronchodilator.

45.

PHYLLOCONTIN

      
Application Number 079202200
Status Registered
Filing Date 1995-09-08
Registration Date 1996-10-18
Owner Purdue Pharma (Canada)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical specialties for human and veterinary use, namely, bronchodilators.

46.

MS.IR

      
Application Number 079202700
Status Registered
Filing Date 1995-09-08
Registration Date 1996-10-18
Owner Purdue Pharma (Canada)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Analgesic preparation.

47.

HYDROMORPH CONTIN

      
Application Number 079183100
Status Registered
Filing Date 1995-09-05
Registration Date 1997-03-21
Owner Purdue Pharma (Canada)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Preparation for relief of pain.

48.

COSOPT

      
Application Number 079146800
Status Registered
Filing Date 1995-08-29
Registration Date 1999-11-03
Owner Purdue Pharma (Canada)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Ophthalmic preparations.

49.

ACROCONTIN

      
Application Number 072600100
Status Registered
Filing Date 1993-04-01
Registration Date 1996-05-24
Owner Purdue Pharma (Canada)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Controlled release delivery composition for use as a component of pharmaceutical preparations.

50.

TIMOPTIC-XE

      
Application Number 071628000
Status Registered
Filing Date 1992-11-04
Registration Date 1996-03-22
Owner Purdue Pharma (Canada)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Medicinal preparation for ophthalmic use.

51.

TRUSOPT

      
Application Number 066189100
Status Registered
Filing Date 1990-07-11
Registration Date 1996-08-30
Owner Purdue Pharma (Canada)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations for the treatment of disorders of the eye.

52.

DILAUDID-HP

      
Application Number 052146000
Status Registered
Filing Date 1984-05-03
Registration Date 1986-02-21
Owner Purdue Pharma (Canada)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical product, namely narcotic analgesic for severe pain. (2) Pharmaceutical product, namely analgesic.

53.

ENTEX

      
Application Number 045609800
Status Registered
Filing Date 1980-07-14
Registration Date 1986-07-18
Owner Purdue Pharma (Canada)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Human pharmaceutical preparations for bronchitis, rhinitis, sinusitis, respiratory congestion and related conditions.

54.

TIMOPTIC

      
Application Number 042419100
Status Registered
Filing Date 1978-04-21
Registration Date 1979-11-23
Owner Purdue Pharma (Canada)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Medicinal preparation for opthalmic use.

55.

TIMOPTOL

      
Application Number 041453800
Status Registered
Filing Date 1977-08-19
Registration Date 1979-09-14
Owner Purdue Pharma (Canada)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Medicinal preparation for ophthalmic use.

56.

IDOSCRUB

      
Application Number 032156200
Status Registered
Filing Date 1969-04-15
Registration Date 1970-03-13
Owner Purdue Pharma (Canada)
NICE Classes  ?
  • 03 - Cosmetics and toiletries; cleaning, bleaching, polishing and abrasive preparations
  • 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) A pharmaceutical preparation or soap, namely, a surgical scrub.

57.

CERUMENEX

      
Application Number 024447600
Status Registered
Filing Date 1958-02-24
Registration Date 1962-07-06
Owner Purdue Pharma (Canada)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) A preparation for the removal of ear wax.

58.

SENOKAP

      
Application Number 023993600
Status Registered
Filing Date 1957-03-19
Registration Date 1958-02-28
Owner Purdue Pharma (Canada)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Laxatives.

59.

DILAUDID

      
Application Number 015842700
Status Registered
Filing Date 1932-08-11
Registration Date 1932-10-26
Owner Purdue Pharma (Canada)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) A medical preparation employed as an analgesic, sedative and hypnotic.